GLISTROMA 20MG CAPSULE contains Temozolomide which belongs to the group of medicines called Antineoplastic agents. GLISTROMA 20MG CAPSULE is used to treat specific forms of brain tumors in adults with newly diagnosed glioblastoma multiforme which is used first together with radiotherapy as a concomitant phase of therapy and then used alone as a monotherapy.
It is also used in children (above 3 years) and adults to treat malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma if they return or get worse after standard treatment.
Glioblastoma multiforme is an aggressive type of cancer that affects the brain or spinal cord which is generally characterized by symptoms such as headache, nausea, drowsiness, blurred vision, personality changes and seizures.
Along with this treatment, your doctor might advise you to take liver function tests to assess the hepatotoxicity (injury to liver due to exposure to drug) and function of your liver.
Before taking GLISTROMA 20MG CAPSULE, inform your doctor if you have or ever had hepatitis B infection (serious liver infection).
GLISTROMA 20MG CAPSULE is not recommended for use if you have certain kinds of blood cells which are severely reduced such as white blood cell and platelet count.
GLISTROMA 20MG CAPSULE should be used with caution during pregnancy only if it is clearly necessary and not recommended for use in breastfeeding women.
It is not recommended for use in children below 3 years of age and should be used with caution in children and adolescents (from 3 to 18 years of age). Consult your doctor before taking GLISTROMA 20MG CAPSULE.
The most common side effects of taking GLISTROMA 20MG CAPSULE are loss of appetite, difficulty while speaking, headache, vomiting, nausea, diarrhea, and constipation. Consult and inform your doctor if any of these symptoms gets worse.